DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Retail
Author Program NEWCreate Narrative
PETS logo

PetMed Express, Inc. Stock Price

NasdaqGS:PETS Community·US$34.1m Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 11 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

PETS Share Price Performance

US$1.60
-1.18 (-42.45%)
​
US$2.15
Fair Value
US$1.60
-1.18 (-42.45%)
25.6% undervalued intrinsic discount
US$2.15
Fair Value
Price US$1.60
AnalystConsensusTarget US$2.15
Tue, 23 Jun 26
Fair ValueUS$2.15
Share Pricen/a

PETS Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$2.15 25.6% undervalued intrinsic discount

Cost Cuts And Digital Upgrades Will Strain Future Margins

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
PETS logo
PetMed Express
25.6% undervalued intrinsic discount

Cost Cuts And Digital Upgrades Will Strain Future Margins

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 23 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
PETS logo

PETS: Rural King Partnership And Board Review Will Support Future Upside

Fair Value: US$2.15 25.6% undervalued intrinsic discount
6 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Excellent balance sheet with moderate growth potential.

1 Risk
1 Reward
View Full Analysis

PetMed Express, Inc. Key Details

US$168.9m

Revenue

US$121.7m

Cost of Revenue

US$47.1m

Gross Profit

US$76.4m

Other Expenses

-US$29.3m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-1.39
27.92%
-17.34%
0%
View Full Analysis

About PETS

Founded
1996
Employees
189
CEO
Leslie C. Campbell
WebsiteView website
www.1800petmeds.com

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Recent PETS News & Updates

Recent updates

No updates

PetMed Express, Inc. Competitors

BARK logo

BARK

Symbol: NYSE:BARK
Market cap: US$79.9m
RTMA.F logo

Reitmans (Canada)

Symbol: OTCPK:RTMA.F
Market cap: US$76.6m
NAAS logo

NaaS Technology

Symbol: NasdaqCM:NAAS
Market cap: US$76.5m
PRTS logo

CarParts.com

Symbol: NasdaqCM:PRTS
Market cap: US$73.5m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide